This report contains market size and forecasts of Recombinant Human Follicle-stimulating Hormone in Global, including the following market information:
Global Recombinant Human Follicle-stimulating Hormone Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Recombinant Human Follicle-stimulating Hormone market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
75IU Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Follicle-stimulating Hormone include Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Recombinant Human Follicle-stimulating Hormone companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Follicle-stimulating Hormone Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, by Type, 2022 (%)
75IU
150IU
Others
Global Recombinant Human Follicle-stimulating Hormone Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, by Application, 2022 (%)
Infertility Treatment
Assisted Reproductive Technology
Global Recombinant Human Follicle-stimulating Hormone Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Follicle-stimulating Hormone revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Human Follicle-stimulating Hormone revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Follicle-stimulating Hormone Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Follicle-stimulating Hormone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Follicle-stimulating Hormone Overall Market Size
2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size: 2022 VS 2030
2.2 Global Recombinant Human Follicle-stimulating Hormone Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.2 Top Global Recombinant Human Follicle-stimulating Hormone Companies Ranked by Revenue
3.3 Global Recombinant Human Follicle-stimulating Hormone Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Human Follicle-stimulating Hormone Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Human Follicle-stimulating Hormone Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Human Follicle-stimulating Hormone Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Recombinant Human Follicle-stimulating Hormone Market Size Markets, 2022 & 2030
4.1.2 75IU
4.1.3 150IU
4.1.4 Others
4.2 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
4.2.3 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2030
5.1.2 Infertility Treatment
5.1.3 Assisted Reproductive Technology
5.2 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
5.2.3 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
6.2.3 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.3.2 US Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.4.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.3 France Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.4 U.K. Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.5 Italy Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.6 Russia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.7 Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.8 Benelux Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.5.2 China Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.5 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.6 India Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.6.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.6.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.7.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.3 Israel Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.4 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.5 UAE Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.1.5 Merck Key News
7.2 Ferring
7.2.1 Ferring Corporate Summary
7.2.2 Ferring Business Overview
7.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.2.5 Ferring Key News
7.3 Livzon
7.3.1 Livzon Corporate Summary
7.3.2 Livzon Business Overview
7.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.3.5 Livzon Key News
7.4 Gedeon Richter
7.4.1 Gedeon Richter Corporate Summary
7.4.2 Gedeon Richter Business Overview
7.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.4.5 Gedeon Richter Key News
7.5 GenSci
7.5.1 GenSci Corporate Summary
7.5.2 GenSci Business Overview
7.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.5.5 GenSci Key News
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.6.5 Teva Key News
7.7 ChangChun High & New Technology
7.7.1 ChangChun High & New Technology Corporate Summary
7.7.2 ChangChun High & New Technology Business Overview
7.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.7.5 ChangChun High & New Technology Key News
7.8 ABL
7.8.1 ABL Corporate Summary
7.8.2 ABL Business Overview
7.8.3 ABL Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.8.5 ABL Key News
7.9 Scripps Laboratories
7.9.1 Scripps Laboratories Corporate Summary
7.9.2 Scripps Laboratories Business Overview
7.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.9.5 Scripps Laboratories Key News
7.10 Alphamab Oncology
7.10.1 Alphamab Oncology Corporate Summary
7.10.2 Alphamab Oncology Business Overview
7.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.10.5 Alphamab Oncology Key News
7.11 Hunan Jingfeng Pharmaceutical
7.11.1 Hunan Jingfeng Pharmaceutical Corporate Summary
7.11.2 Hunan Jingfeng Pharmaceutical Business Overview
7.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.11.5 Hunan Jingfeng Pharmaceutical Key News
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Corporate Summary
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.12.5 Qilu Pharmaceutical Key News
7.13 Beijing SL Pharmaceutical
7.13.1 Beijing SL Pharmaceutical Corporate Summary
7.13.2 Beijing SL Pharmaceutical Business Overview
7.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.13.5 Beijing SL Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Recombinant Human Follicle-stimulating Hormone Market Opportunities & Trends in Global Market
Table 2. Recombinant Human Follicle-stimulating Hormone Market Drivers in Global Market
Table 3. Recombinant Human Follicle-stimulating Hormone Market Restraints in Global Market
Table 4. Key Players of Recombinant Human Follicle-stimulating Hormone in Global Market
Table 5. Top Recombinant Human Follicle-stimulating Hormone Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Human Follicle-stimulating Hormone Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Human Follicle-stimulating Hormone Product Type
Table 9. List of Global Tier 1 Recombinant Human Follicle-stimulating Hormone Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2023-2030
Table 30. Merck Corporate Summary
Table 31. Merck Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 32. Merck Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 33. Ferring Corporate Summary
Table 34. Ferring Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 35. Ferring Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 36. Livzon Corporate Summary
Table 37. Livzon Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 38. Livzon Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 39. Gedeon Richter Corporate Summary
Table 40. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 41. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 42. GenSci Corporate Summary
Table 43. GenSci Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 44. GenSci Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 45. Teva Corporate Summary
Table 46. Teva Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 47. Teva Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 48. ChangChun High & New Technology Corporate Summary
Table 49. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 50. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 51. ABL Corporate Summary
Table 52. ABL Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 53. ABL Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 54. Scripps Laboratories Corporate Summary
Table 55. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 56. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 57. Alphamab Oncology Corporate Summary
Table 58. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 59. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 60. Hunan Jingfeng Pharmaceutical Corporate Summary
Table 61. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 62. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 63. Qilu Pharmaceutical Corporate Summary
Table 64. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 65. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
Table 66. Beijing SL Pharmaceutical Corporate Summary
Table 67. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 68. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Recombinant Human Follicle-stimulating Hormone Segment by Type in 2022
Figure 2. Recombinant Human Follicle-stimulating Hormone Segment by Application in 2022
Figure 3. Global Recombinant Human Follicle-stimulating Hormone Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Follicle-stimulating Hormone Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2022
Figure 8. By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 9. By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 10. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 11. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 12. US Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 16. Germany Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 17. France Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 24. China Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 28. India Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 30. Brazil Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
Figure 33. Turkey Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2030
Figure 37. Merck Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Ferring Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Livzon Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. GenSci Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ABL Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
